Microbot Medical Inc. (MBOT)

Every figure below is the company's own, as filed. Nothing is estimated and nothing is smoothed — a period the filing does not support is left blank rather than drawn. Quarters are the company's own, counted from its financial year ending 12-31. Amounts in USD.

Revenue Annual

0 500K 1M 1.5M FY09: 992.9K FY10: 1.4M FY11: 1.2M FY12: 1.4M FY13: 172.3K FY15: 116.9K FY09 FY10 FY11 FY12 FY13 FY15

Gross Profit Annual

0 500K 1M 1.5M FY09: 731.4K FY10: 1.3M FY11: 1M FY12: 1.1M FY13: 886.6K FY09 FY10 FY11 FY12 FY13

Operating Income Annual

-45M -30M -15M 0 15M 30M 45M FY09: -29.4M FY10: -29.4M FY11: -28.1M FY12: -21.9M FY13: -28.1M FY14: -30.9M FY15: 915K FY16: -9.6M FY17: 5.3M FY18: -7.2M FY19: -7.2M FY20: -9.1M FY21: -11.4M FY22: -13.3M FY23: -9.9M FY24: -11.6M FY25: -14.7M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Net Income Annual

-45M -30M -15M 0 15M 30M 45M FY09: -27M FY10: -25.2M FY11: -21.3M FY12: -28.5M FY13: -26.4M FY14: -32.7M FY15: -921K FY16: -9.7M FY17: -7.6M FY18: -7.3M FY19: -7.2M FY20: -9.2M FY21: -11.3M FY22: -13.2M FY23: -10.7M FY24: -11.4M FY25: -13.1M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Cost of Revenue Annual

Nothing in this filer's XBRL supports this figure for the periods asked for, so there is nothing to draw. That is a gap in the filing, not a zero.

Operating Cash Flow Annual

-30M -20M -10M 0 10M 20M 30M FY09: -24.7M FY10: -24.5M FY11: -22.1M FY12: -19.9M FY13: -23.3M FY14: -27.4M FY15: -765K FY16: -786K FY17: -4.9M FY18: -5.3M FY19: -6.5M FY20: -7.3M FY21: -9.4M FY22: -11.5M FY23: -8.5M FY24: -8.8M FY25: -13M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Free Cash Flow Annual

-30M -20M -10M 0 10M 20M 30M FY09: -25.4M FY10: -25.4M FY11: -22.4M FY12: -19.9M FY13: -28M FY14: -28.3M FY15: -767K FY16: -811K FY17: -4.9M FY18: -5.5M FY19: -6.7M FY20: -7.3M FY21: -9.4M FY22: -11.6M FY23: -8.6M FY24: -8.9M FY25: -13.1M FY09 FY11 FY13 FY15 FY17 FY19 FY21 FY23 FY25

Operating cash flow minus capital expenditure.

Shares Outstanding Annual

0 20M 40M 60M FY21: 7.1M FY22: 7.3M FY23: 10.2M FY24: 15.6M FY25: 45.8M FY21 FY22 FY23 FY24 FY25

Weighted average diluted, as the filer reports it for each period. An average cannot be added across periods, so this one is always shown per period the filer tagged rather than as a trailing year.

EPS TTM

-4.50 -3.00 -1.50 0.00 1.50 3.00 4.50 Q4 '10: -2.05 Q1 '11: -1.96 Q2 '11: -1.87 Q3 '11: -1.74 Q4 '11: -1.50 Q1 '12: -1.53 Q2 '12: -1.21 Q3 '12: -1.44 Q4 '12: -1.03 Q1 '13: -0.75 Q2 '13: -0.93 Q3 '13: -0.56 Q4 '13: -0.62 Q1 '14: -0.59 Q2 '14: -0.66 Q3 '14: -0.53 Q4 '14: -0.55 Q1 '15: -2.03 Q2 '15: -2.88 Q3 '15: -3.91 Q4 '15: -3.84 Q1 '16: -2.23 Q2 '16: -1.17 Q3 '16: -0.18 Q4 '16: 0.39 Q1 '17: 0.44 Q2 '17: 0.36 Q3 '17: -0.01 Q4 '17: -1.01 Q1 '18: -1.55 Q2 '18: -2.12 Q3 '18: -2.27 Q4 '18: -2.38 Q1 '19: -2.36 Q2 '19: -2.06 Q3 '19: -1.90 Q4 '19: -1.71 Q1 '20: -1.54 Q2 '20: -1.44 Q3 '20: -1.35 Q4 '20: -1.29 Q1 '21: -1.32 Q2 '21: -1.41 Q3 '21: -1.42 Q4 '21: -1.59 Q1 '22: -1.70 Q2 '22: -1.84 Q3 '22: -1.97 Q4 '22: -1.81 Q1 '23: -1.72 Q2 '23: -1.48 Q3 '23: -1.20 Q4 '23: -1.08 Q1 '24: -0.89 Q2 '24: -0.81 Q3 '24: -0.80 Q4 '24: -0.74 Q1 '25: -0.65 Q2 '25: -0.58 Q3 '25: -0.45 Q4 '25: -0.29 Q1 '26: -0.26 Q2 '26: -0.24 Q2 '12 Q2 '14 Q2 '16 Q2 '18 Q2 '20 Q2 '22 Q2 '24 Q2 '26

The filer's own published earnings a share for each quarter, four quarters added up. The company page divides trailing net income by the share count instead, which lands within about 1% of this and is not the same sum, so the two are named differently rather than presented as one figure.